Isoflurane pp 311-316 | Cite as

Isoflurane for Patients with Respiratory Diseases

  • T. Pasch
  • H.-D Kamp
  • H. Petermann
Conference paper
Part of the Anaesthesiology Intensive Care Medicine/Anaesthesiologie und Intensivmedizin book series (A+I, volume 182)


The selection of anaesthetic agents depends not only on their specific anaesthetic actions, but also on their effects on various organs and functional systems including cardiovascular and respiratory systems, hepatic and renal functions, metabolism, etc. This must be considered in particular when the patient presents with diseases affecting these systems.


Chronic Obstructive Pulmonary Disease Airway Resistance Status Asthmaticus Volatile Agent Peripheral Chemoreceptor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Augustine SD, Benumof JL (1984) Halothane and isoflurane do not impair arterial oxygenation during one lung ventilation in patients undergoing thoracotomy. Anesthesiology 61: A484CrossRefGoogle Scholar
  2. 2.
    Bjertnaes LJ (1985) Volatile Anasthetika und ihr Effekt auf die Atmung. In: Peter K, Brown BR, Martin E, Norlander O (eds) Inhalationsanaesthetika - Neue Aspekte. Springer, Berlin Heidelberg New York Tokyo, p 119 (Anaesthesiol intens care med vol 184 )Google Scholar
  3. 3.
    Bjertnaes L, Mundal R, Hauge A, Nicolaysen (1980) Vascular resistance in atelectatic lungs: effects of inhalation anesthetics. Acta Anaesthesiol Scand k24: 109PubMedCrossRefGoogle Scholar
  4. 4.
    Calaco CM, Crago RR, Weisbert A (1978) Halothane for status asthmaticus in the intensive care unit - a case report. Can Anaesth Soc J 25: 329CrossRefGoogle Scholar
  5. 5.
    Eger EI (1984) The pharmacology of isoflurane. Br J Anaesth 56:71 SPubMedGoogle Scholar
  6. 6.
    Gold MI (1983) Bronchospasm and asthma in the anesthetized patient. 34th annu refresher course lectures, no 201. ASA, AtlantaGoogle Scholar
  7. 7.
    Gold MI, Schwam SJ, Goldberg M (1983) Chronic obstructive pulmonary disease and respiratory complications. Anesth Analg 62: 975PubMedCrossRefGoogle Scholar
  8. 8.
    Hack G, Rommelsheim V, Pless V, Stoeckel H (1976) Bronchospasmus unter Enfluraneanästhesie. Prakt Anästh 11: 264Google Scholar
  9. 9.
    Heneghan CPH, Bergman NA, Jordan C, Lehane JR, Catley DM (1983) Effect of isoflurane on bronchomotor tone. Br J Anaesth 55: 248 PGoogle Scholar
  10. 10.
    Hirshman (1984) Anesthesia and bronchospastic disease. 35th annu refresher course lectures, no 138. ASA, New OrleansGoogle Scholar
  11. 11.
    Hirshman CA, Bergman NA (1978) Halothane and enflurane protect against bronchospasm in an asthma dog model. Anesth Analg 57: 629PubMedCrossRefGoogle Scholar
  12. 12.
    Hirshman CA, Edelstein G, Peetz S, Wayne R, Downes H (1982) Mechanism of action of inhalational anesthesia on airways. Anesthesiology 56: 107PubMedCrossRefGoogle Scholar
  13. 13.
    Kamp HD, Pasch T, Schmiedl R (1983) Verhalten atemmechanischer Parameter unter Isoflurane- Anasthesie. In: Peter K (ed) Symposium Isoflurane — Experimentelle und klinische Aspekte. Excerpta Medica, Amsterdam, p 87Google Scholar
  14. 14.
    Knill RL, Kiereaszewicz HT, Dodgson BG, Clement JL (1983) Chemical regulation of ventilation during isoflurane sedation and anaesthesia in humans. Can Anaesth Soc J 30: 607PubMedCrossRefGoogle Scholar
  15. 15.
    Lehane JR, Jordan C, Jones JG (1980) Influence of halothane and enflurane on respiratory airflow resistance and specific conductance in anaesthetized man. Br J Anaesth 52: 773PubMedCrossRefGoogle Scholar
  16. 16.
    Marshall BE, Marshall C (1985) Anesthesia and pulmonary circulation. In: Covino BG, Fozzard HA, Rehder K, Stichartz G (eds) Effects of anesthesia. Am Physiol Soc, Bethesda, p 121Google Scholar
  17. 17.
    O’Rourke PP, Crone RK (1982) Halothane in status asthmaticus. Crit Care Med 10: 341PubMedCrossRefGoogle Scholar
  18. 18.
    Pavlin EG (1981) Respiratory pharmacology of inhaled anesthetic agents. In: Miller RD (ed) Anesthesia, vol 1. Livingstone, New York, p 349Google Scholar
  19. 19.
    Pietak S, Weenig CS, Hickey RF, Fairley HB (1975) Anesthetic effects on ventilation in patients with chronic obstructive pulmonary disease. Anesthesiology 42: 160PubMedCrossRefGoogle Scholar
  20. 20.
    Rehder K, Mallow JE, Fibuch EE, Krabill DR, Sessler AD (1974) Effects of isoflurane anesthesia and muscle paralysis on respiratory mechanics in normal man. Anesthesiology 41: 477PubMedCrossRefGoogle Scholar
  21. 21.
    Rosseell P, Lauwers LF, Baute L (1985) Halothane treatment in life-threatening asthma. Intens Care Med 11: 241CrossRefGoogle Scholar
  22. 22.
    Schwartz SH (1984) Treatment of status asthmaticus with halothane. JAMA 251: 2688PubMedCrossRefGoogle Scholar
  23. 23.
    Schwettmann RS, Casterline CL (1976) Delayed asthmatic response following occupational exposure to enflurane. Anesthesiology 44: 166PubMedCrossRefGoogle Scholar
  24. 24.
    Stirt J A, Berger JM, Sullivan SF (1983) Lack of arrhythmogenicity of isoflurane following administration of aminophylline in dogs. Anesth Analg 62: 568PubMedGoogle Scholar
  25. 25.
    Welch WD (1985) Enflurane and isoflurane inhibit the oxidative activity of pulmonary alveolar macrophages. Respiration 47: 24PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • T. Pasch
  • H.-D Kamp
  • H. Petermann

There are no affiliations available

Personalised recommendations